Hostname: page-component-745bb68f8f-g4j75 Total loading time: 0 Render date: 2025-01-13T06:53:11.083Z Has data issue: false hasContentIssue false
  • English
  • Français

The impact of pricing and patent expiration on demand for pharmaceuticals: an examination of the use of broad-spectrum antimicrobials

Published online by Cambridge University Press:  04 September 2012

Klaus Kaier
Klaus Kaier*
Affiliation:
Department of Environmental Health Sciences, University Medical Center Freiburg, Germany Research Center for Generational Contracts, Freiburg University, Germany
*
*Correspondence to: Klaus Kaier, Department of Environmental Health Sciences, University Medical Center Freiburg, Breisacher Straße 115b, D-79106 Freiburg, Germany. Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

The aim of the analysis was to determine whether demand in Germany for specific antimicrobial agents is driven by prices that drop considerably when generic substitutes become available. A time-series approach was therefore carried out to explore price elasticities of demand for two different classes of broad-spectrum antimicrobials (fluoroquinolones and cephalosporins) using data on ambulatory antibiotics prescribed on the German statutory health insurance scheme and data on in-hospital antibiotic use in a German teaching hospital. In short, we attempted to explain demand for different antibiotics based on changes in price and hospital-wide morbidity. The data indicate that patent expiration is followed by substantial decreases in the price of antibiotics. In the outpatient sector, all antibiotics included in the analysis showed significant negative own-price elasticities of demand. However, in the hospital settings, significant own-price elasticities were only determined for some antibiotics, although price decreases were stronger than in the outpatient sector. We conclude that price dependence of demand for antimicrobials is present both in the ambulatory and the hospital setting. However, this is especially surprising in the hospital setting because price differences among the antibiotics observed are particularly small compared with the overall cost of hospitalisation.

Type
Articles
Information
Health Economics, Policy and Law , Volume 8 , Issue 1 , January 2013 , pp. 7 - 20
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aldeyab, M. A., Monnet, D. L., Lopez-Lozano, J. M., Hughes, C. M., Scott, M. G., Kearney, M. P., Magee, F. A.McElnay, J. C. (2008), ‘Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis’, Journal of Antimicrobial Chemotherapy, 62: 593–600.Google Scholar
Aldeyab, M. A., Harbarth, S., Vernaz, N., Kearney, M. P., Scott, M. G., Funston, C., Savage, K., Kelly, D., Aldiab, M. A.McElnay, J. C. (2009), ‘Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients’, Antimicrobial Agents and Chemotherapy, 53: 2082–2088.Google Scholar
Arellano, M. (1987), ‘Computing robust standard errors for within groups estimators’, Oxford Bulletin of Economics and Statistics, 49: 431–434.CrossRefGoogle Scholar
Baye, M. R., Maness, R.Wiggins, S. N. (1997), ‘Demand systems and the true subindex of the cost of living for pharmaceuticals’, Applied Economics, 29: 1179–1189.Google Scholar
Busse, R.Riesberg, A. (2004), Health Care Systems in Transition – Germany, Copenhagen: World Health Organization on behalf of the European Observatory on Health Systems and Policies.Google Scholar
Cosgrove, S. E.Carmeli, Y. (2003), ‘The impact of antimicrobial resistance on health and economic outcomes’, Clinical Infectious Diseases, 36: 1433–1437.Google Scholar
de With, K., Schröder, H., Meyer, E., Nink, K., Hoffmann, S., Steib-Bauert, M., Kämmerer, R., Rueß, S., Daschner, F. D.Kern, W. V. (2004), ‘Antibiotic use in Germany and Europe’, Deutsche Medizinische Wochenschrift, 129: 1987–1992 (in German).Google Scholar
Eisenberg, J. M. (2002), ‘Physician utilization: the state of research about physicians’ practice patterns’, Medical Care, 40: 1016–1035.Google Scholar
Ellison, S. F., Cockburn, I., Griliches, Z.Hausman, J. (1997), ‘Characteristics of demand for pharmaceutical products: an examination of four cephalosporins’, The Rand Journal of Economics, 28: 426–446.Google Scholar
Filippini, M., Masiero, G.Moschetti, K. (2006), ‘Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland’, Health Policy, 78: 77–92.Google Scholar
Filippini, M., Masiero, G.Moschetti, K. (2008), ‘Small area variations and welfare loss in the use of outpatient antibiotics’, Health Economics, Policy and Law, 4: 55–77.CrossRefGoogle Scholar
Frank, U. (2008), Antibiotika am Krankenbett, Heidelberg: Springer Medizin Verlag.Google Scholar
Frank, U.Tacconelli, E. (2009), The Daschner Guide to In-Hospital Antibiotic Therapy, Heidelberg: Springer Medizin Verlag.Google Scholar
Goossens, H., Ferech, M., Vander Stichele, R.Elseviers, M. (2005), ‘Outpatient antibiotic use in Europe and association with resistance: a cross-national database study’, The Lancet, 365: 579–587.Google Scholar
Griliches, Z.Cockburn, I. (1994), ‘Generics and new goods in pharmaceutical price indexes’, The American Economic Review, 84: 1213–1232.Google Scholar
Kaier, K., Hagist, C., Frank, U., Conrad, A.Meyer, E. (2009a), ‘Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection’, Infection Control and Hospital Epidemiology, 30: 346–353.Google Scholar
Kaier, K., Frank, U., Hagist, C., Conrad, A.Meyer, E. (2009b), ‘The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum {beta}-lactamase-producing strains: a time-series analysis’, Journal of Antimicrobial Chemotherapy, 63: 609–614.Google Scholar
Kaier, K., Wilson, C., Chalkley, M., Davey, P., Suetens, C., Grundmann, H., de Kraker, M., Schumacher, M., Wolkewitz, M.Frank, U. (2008), ‘Health and economic impacts of antibiotic resistance in European hospitals – outlook on the BURDEN project’, Infection, 36: 492–494.Google Scholar
Levy, S. B. (1992), The Antibiotic Paradox: How Miracle Drugs Destroying the Miracle, New York, London: Plenum Press.Google Scholar
Levy, S. B.Marshall, B. (2004), ‘Antibacterial resistance worldwide: causes, challenges and responses’, Nature Medicine, 10, Supplement 12: S122–S129.Google Scholar
Lisac, M., Reimers, L., Henke, K. D.Schlette, S. (2010), ‘Access and choice – competition under the roof of solidarity in German health care: an analysis of health policy reforms since 2004’, Health Economics, Policy and Law, 5: 31–52.Google Scholar
Monnet, D. L., MacKenzie, F. M., Lopez-Lozano, J. M., Beyaert, A., Camacho, M., Wilson, R., Stuart, D.Gould, I. M. (2004), ‘Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996–2000’, Emerging Infectious Diseases, 10: 1432–1441.Google Scholar
Paladino, J. A., Sunderlin, J. L., Price, C. S.Schentag, J. J. (2002), ‘Economic consequences of antimicrobial resistance’, Surgical Infections, 3: 259–267.Google Scholar
Shorr, A. F. (2007), ‘Epidemiology and economic impact of methicillin-resistant Staphylococcus aureus: review and analysis of the literature’, Pharmacoeconomics, 25: 751–768.Google Scholar
Smith, R. D., Yago, M., Millar, M.Coast, J. (2005), ‘Assessing the macroeconomic impact of a healthcare problem: the application of computable general equilibrium analysis to antimicrobial resistance’, Journal of Health Economics, 24: 1055–1075.Google Scholar
Smith, R. D., Yago, M., Millar, M.Coast, J. (2006), ‘A macroeconomic approach to evaluating policies to contain antimicrobial resistance: a case study of methicillin-resistant Staphylococcus aureus (MRSA)’, Applied Health Economics and Health Policy, 5: 55–65.CrossRefGoogle ScholarPubMed
Vernaz, N., Sax, H., Pittet, D., Bonnabry, P., Schrenzel, J.Harbarth, S. (2008), ‘Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile’, Journal of Antimicrobial Chemotherapy, 62: 601–607.Google Scholar
World Health Organization (WHO) (2000), ‘Overcoming antimicrobial resistance’. http://www.who.int/infectious-disease-report/2000/index.htmlGoogle Scholar
Zerbe, P.Heisterkamp, U. (1995), Pflege-Personalregelung: ein Leitfaden zur praktischen Anwendung der Stellenplanberechnung im Pflegedienst, Hannover, Germany: Schlütersche Verlag.Google Scholar